The 8th Obesity & NASH Drug Development Summit is dedicated to Non-Alcoholic Steatohepatitis challenges from drug discovery to late stage clinical development.
The 8th Obesity & NASH Drug Development Summit covers topics such as:
- Validation of non-invasive biomarker approaches and technologies to more robustly diagnose and track disease progression
- How to optimize recapitulation of human NASH in vivo and effectively translate into the clinic
- Clinical primary and secondary endpoints and road-map for regulatory path to approval
- Ways to improve drug efficacy in both early and late stage NASH by identifying and validating novel targets and drug mechanisms of action
- Join your peers in Cambridge, MA, to overcome the challenges that are preventing you from accelerating the development of your NASH candidate
The 8th Obesity & NASH Drug Development Summit brings together drug developers.
The 8th Obesity & NASH Drug Development Summit might be held in Sep 2024.